Shuji Ozaki

14PUBLICATIONS
41CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyRespiratory diseasesGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Shaji Kumar, Sundar Jagannath, Katja C Weisel

|Feb 19, 2026
Assessment of Predictive Factors That Shorten Duration of Treatment in Patients With Multiple Myeloma Using AI: Real-World Longitudinal Study Using Data From Medical Data Vision Claims Database.

Hiroshi Handa, Tadao Ishida, Shuji Ozaki

|Nov 07, 2025
Marked Platelet Clumping and Giant Platelets due to GP Ib/IX Autoantibodies.

Tatsuya Fukuyama, Tomoko Maruhashi, Makiko Mizuguchi

|May 19, 2023
Systemic osteosclerosis associated with primary bone marrow B-cell lymphoma.

Shuji Ozaki, Tsutomu Iima, Etsuko Sekimoto

|Apr 06, 2023
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database.

Hiroshi Handa, Tadao Ishida, Shuji Ozaki

|Jan 24, 2023
Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice.

Makiko Mizuguchi, Yasunobu Okamoto, Hikaru Yagi

Pageof 3

Frequent Collaborators

1 joint publications

Akitada Ichinose

1 joint publications

Yurie Miyamoto-Nagai

1 joint publications

Chiaki Nakaseko

1 joint publications

Takeshi Harada